Myeloproliferative disease and cancer in persons with Noonan syndrome and related disorders

Monographs in Human Genetics

Volumn 17, Issue , 2009, Pages 119-127

  Kratz, C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870153976     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000164848     Document Type: Review

References (74)

1. Khan S, McDowell H, Upadhyaya M, Fryer A: Vaginal rhabdomyosarcoma in a patient with Noonan syndrome. J Med Genet 1995;32:743-745.
2. Jung A, Bechthold S, Pfluger T, Renner C, Ehrt O: Orbital rhabdomyosarcoma in Noonan syndrome. J Pediatr Hematol Oncol 2003;25:330-332. (Pubitemid 36506224)
3. Moschovi M, Vassiliki T, Anna P, Maria-Alexandra M, Polyxeni NK, Kitsiou-Tzeli S: Rhabdomyosarcoma in a patient with Noonan syndrome phenotype and review of the literature. J Pediatr Hematol Oncol 2007;29:341-344. (Pubitemid 46707519)
4. Kerr B, Eden OB, Dandamudi R, Shannon N, Quarrell O, et al: Costello syndrome: two cases with embryonal rhabdomyosarcoma. J Med Genet 1998;35:1036-1039. (Pubitemid 28534680)
5. Gripp KW, Lin AE, Stabley DL, Nicholson L, Scott CI Jr, et al: HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation. Am J Med Genet A 2006;140:1-7. (Pubitemid 43054028)
6. Feingold M: Costello syndrome and rhabdomyosarcoma. J Med Genet 1999;36:582-583.
7. Bisogno G, Murgia A, Mammi I, Strafella MS, Carli M: Rhabdomyosarcoma in a patient with cardio-facio-cutaneous syndrome. J Pediatr Hematol Oncol 1999;21:424-427. (Pubitemid 30306014)
8. Sigaudy S, Vittu G, David A, Vigneron J, Lacombe D, et al: Costello syndrome: report of six patients including one with an embryonal rhabdomyosarcoma. Eur J Pediatr 2000;159:139-142. (Pubitemid 30139935)
9. Kawame H: [Costello syndrome]. Ryoikibetsu Shokogun Shirizu 2001;33:497-498.
10. Gripp KW, Scott CI Jr, Nicholson L, McDonald-McGinn DM, Ozeran JD, et al: Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol. Am J Med Genet 2002;108:80-87.
11. Kerr B, Einaudi MA, Clayton P, Gladman G, Eden T, et al: Is growth hormone treatment beneficial or harmful in Costello syndrome? J Med Genet 2003;40:e74.
12. O'Neal JP, Ramdas J, Wood WE, Pellitteri PK: Parameningeal rhabdomyosarcoma in a patient with Costello syndrome. J Pediatr Hematol Oncol 2004;26:389-392. (Pubitemid 38747732)
13. Gripp KW: Tumor predisposition in Costello syndrome. Am J Med Genet C Semin Med Genet 2005;137:72-77. (Pubitemid 41113664)
14. Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, et al: Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 2005;37:1038-1040. (Pubitemid 41486653)
15. Kerr B, Delrue MA, Sigaudy S, Perveen R, Marche M, et al: Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 2006;43:401-405.
16. Estep AL, Tidyman WE, Teitell MA, Cotter PD, Rauen KA: HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wildtype allele in malignancy. Am J Med Genet A 2006;140:8-16. (Pubitemid 43054029)
17. Bader-Meunier B, Tchernia G, Mielot F, Fontaine JL, Thomas C, et al: Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997;130:885-889. (Pubitemid 27495115)
18. Fukuda M, Horibe K, Miyajima Y, Matsumoto K, Nagashima M: Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome. J Pediatr Hematol Oncol 1997;19:177-179.
19. Choong K, Freedman MH, Chitayat D, Kelly EN, Taylor G, Zipursky A: Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol 1999;21:523-527. (Pubitemid 30305988)
20. Silvio F, Carlo L, Elena B, Nicoletta B, Daniela F, Roberto M: Transient abnormal myelopoiesis in Noonan syndrome. J Pediatr Hematol Oncol 2002;24:763-764. (Pubitemid 35448745)
21. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, et al: Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003;34:148-150. (Pubitemid 36666923)
22. Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, et al: Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 2004;103:2325-2331. (Pubitemid 38326253)
23. Jongmans M, Otten B, Noordam K, Van der Burgt I: Genetics and variation in phenotype in Noonan syndrome. Horm Res 2004;62(Suppl) 3:56-59.
24. Yoshida R, Miyata M, Nagai T, Yamazaki T, Ogata T: A 3-bp deletion mutation of PTPN11 in an infant with severe Noonan syndrome including hydrops fetalis and juvenile myelomonocytic leukemia. Am J Med Genet A 2004;128:63-66. (Pubitemid 38856821)
25. Giovannini L, Cave H, Ferrero-Vacher C, Boutte P, Sirvent N: A new PTPN11 mutation in juvenile myelomonocytic leukaemia associated with Noonan syndrome. Acta Paediatr 2005;94:636-637. (Pubitemid 40646693)
26. Kratz C P, Niemeyer CM, Castleberry RP, Cetin M, Bergstrasser E, et al: The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 2005;106:2183-2185. (Pubitemid 41291737)
27. Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, et al: Germline KRAS mutations cause Noonan syndrome. Nat Genet 2006;38:331-336.
28. Cheong JL, Moorkamp MH: Respiratory failure, juvenile myelomonocytic leukemia, and neonatal Noonan syndrome. J Pediatr Hematol Oncol 2007;29:262-264. (Pubitemid 46597692)
29. Kratz CP, Nathrath M, Freisinger P, Dressel P, Assmuss HP, et al: Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation. Eur J Pediatr 2006;165:182-185. (Pubitemid 43199158)
30. Merino AH, Etxeandia IA, Borja BB, Olivera IA: Sindrome de Noonan asociado a leucosis aguda linfoblastica. An Esp Pediatr 1982;17:78-80.
31. Hernandez Merino A, Asolo Etxeandia I, Bernacer Borja M, Azcona Olivera I: Noonan syndrome associated with acute lymphoblastic leukosis. An Esp Pediatr 1982;17:78-80.
32. Piombo M, Rosanda C, Pasino M, Marasini M, Cerruti P, Comelli A: Acute lymphoblastic leukemia in Noonan syndrome: report of two cases. Med Pediatr Oncol 1993;21:454-455. (Pubitemid 23202825)
33. Attard-Montalto SP, Kingston JE, Eden T: Noonan's syndrome and acute lymphoblastic leukaemia. Med Pediatr Oncol 1994;23:391-392. (Pubitemid 24282403)
34. Johannes JM, Garcia ER, De Vaan GA, Weening RS: Noonan's syndrome in association with acute leukemia. Pediatr Hematol Oncol 1995;12:571-575.
35. Merks JH, Caron HN, Hennekam RC: High incidence of malformation syndromes in a series of 1, 073 children with cancer. Am J Med Genet A 2005;134:132-143. (Pubitemid 40446208)
36. Roti G, La Starza R, Ballanti S, Crescenzi B, Romoli S, et al: Acute lymphoblastic leukaemia in Noonan syndrome. Br J Haematol 2006;133:448-450.
37. Karow A, Steinemann D, Gohring G, Hasle H, Greiner J, et al: Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome. Leukemia 2007;21:1303-1305. (Pubitemid 46831821)
38. Van Den Berg H, Hennekam RC: Acute lymphoblastic leukaemia in a patient with cardiofaciocutaneous syndrome. J Med Genet 1999;36:799-800. (Pubitemid 29462332)
39. Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, et al: Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 2006;38:294-296.
40. Makita Y, Narumi Y, Yoshida M, Niihori T, Kure S, et al: Leukemia in Cardiofacio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene. J Pediatr Hematol Oncol 2007;29:287-290. (Pubitemid 46707505)
41. Matsubara K, Yabe H, Ogata T, Yoshida R, Fukaya T: Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation. Am J Hematol 2005;79:171-172. (Pubitemid 40770681)
42. Chantrain CF, Jijon P, De Raedt T, Vermylen C, Poirel HA, Legius E, Brichard B: Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation. Pediatr Blood Cancer 2007;48:101-104. (Pubitemid 44871599)
43. Ucar C, Calyskan U, Martini S, Heinritz W: Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive). J Pediatr Hematol Oncol 2006;28:123-125. (Pubitemid 43791807)
44. Lopez-Miranda B, Westra SJ, Yazdani S, Boechat MI: Noonan syndrome associated with neuroblastoma: a case report. Pediatr Radiol 1997;27:324-326. (Pubitemid 27174306)
45. Cotton JL, Williams RG: Noonan syndrome and neuroblastoma. Arch Pediatr Adolesc Med 1995;149:1280-1281.
46. Ijiri R, Tanaka Y, Keisuke K, Masuno M, Imaizumi K: A case of Noonan's syndrome with possible associated neuroblastoma. Pediatr Radiol 2000;30:432-433. (Pubitemid 30330454)
47. Zampino G, Mastroiacovo P, Ricci R, Zollino M, Segni G, Martini-Neri ME, Neri G: Costello syndrome: further clinical delineation, natural history, genetic definition, and nosology. Am J Med Genet 1993;47:176-183. (Pubitemid 23240687)
48. Moroni I, Bedeschi F, Luksch R, Casanova M, D'Incerti L, Uziel G, Selicorni A: Costello syndrome: a cancer predisposing syndrome? Clin Dysmorphol 2000;9:265-268.
49. Flores-Nava G, Canun-Serrano S, Moysen-Ramirez SG, Parraguirre-Martinez S, Escobedo-Chavez E: [Costello syndrome associated to a neuroblastoma. Presentation of a case]. Gac Med Mex 2000;136:605-609.
50. Zampino G, Pantaleoni F, Carta C, Cobellis G, Vasta I, et al: Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. Hum Mutat 2007;28:265-272.
51. Franceschini P, Licata D, Di Cara G, Guala A, Bianchi M, Ingrosso G, Franceschini D: Bladder carcinoma in Costello syndrome: report on a patient born to consanguineous parents and review. Am J Med Genet 1999;86:174-179. (Pubitemid 29400348)
52. Gripp KW, Scott CI Jr, Nicholson L, Figueroa TE: Second case of bladder carcinoma in a patient with Costello syndrome. Am J Med Genet 2000;90:256-259. (Pubitemid 30051878)
53. Urakami S, Igawa M, Shiina H, Shigeno K, Kikuno N, Yoshino T: Recurrent transitional cell carcinoma in a child with the Costello syndrome. J Urol 2002;168:1133-1134.
54. Gripp KW, Lin AE, Nicholson L, Allen W, Cramer A, et al: Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome. Am J Med Genet A 2007;143:1472-1480. (Pubitemid 47051026)
55. Al-Rahawan MM, Chute DJ, Sol-Church K, Gripp KW, Stabley DL, et al: Hepatoblastoma and heart transplantation in a patient with cardio-faciocutaneous syndrome. Am J Med Genet A 2007;143:1481-1488. (Pubitemid 47051027)
56. La Starza R, Rosati R, Roti G, Gorello P, Bardi A, et al: A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome. Leukemia 2007;21:830-833. (Pubitemid 46444578)
57. Aggarwal A, Krishnan J, Kwart A, Perry D: Noonan's syndrome and seminoma of undescended testicle. South Med J 2001;94:432-434. (Pubitemid 33643436)
58. Sriram K, Thomas K, Barnes R: Noonan's syndrome. With carcinoma of undescended testis. IMJ Ill Med J 1987;171:294-296.
59. Riederer J: ['Benign' monoclonal gammopathy and chronic lymphatic leukemia in a patient with Noonan syndrome]. Med Klin (Munich) 1998;93:433-437. (Pubitemid 28346441)
60. Wilcox W D: Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1998;132:189-190. (Pubitemid 28082562)
61. Niemeyer CM, Kratz C: Juvenile myelomonocytic leukemia. Curr Oncol Rep 2003;5:510-515. (Pubitemid 38898823)
62. Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, et al: Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005;105:410-419. (Pubitemid 40053113)
63. Kratz CP, Niemeyer CM, Zenker M: An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med 2007;85:223-231. (Pubitemid 46295245)
64. Flotho C, Steinemann D, Mullighan CG, Neale G, Mayer K, et al: Genomewide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11. Oncogene 2007;26:5816-5821. (Pubitemid 47312813)
65. Stephens K, Weaver M, Leppig KA, Maruyama K, Emanuel PD, Le Beau MM, Shannon KM: Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood 2006;108:1684-1689. (Pubitemid 44316138)
66. Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, et al: Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci USA 2004;101:597-602. (Pubitemid 38084682)
67. Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, et al: Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 2004;103:4243-4250. (Pubitemid 38685370)
68. Kratz CP, Niemeyer CM, Thomas C, Bauhuber S, Matejas V, et al: Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia. Leukemia 2007;21:1108-1109. (Pubitemid 46672093)
69. Wexler LH, Helman LJ: Pediatric soft tissue sarcomas. CA Cancer J Clin 1994;44:211-247. (Pubitemid 24247792)
70. Kratz CP, Steinemann D, Niemeyer CM, Schlegelberger B, Koscielniak E, Kontny U, Zenker M: Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. Hum Mol Genet 2007;16:374-379. (Pubitemid 46323174)
71. Schubbert S, Shannon K, Bollag G: Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007;7:295-308. (Pubitemid 46480970)
72. Shukla V, Coumoul X, Wang RH, Kim HS, Deng CX: RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 2007;39:1145-1150. (Pubitemid 47340648)
73. Wilkie AO: Cancer drugs to treat birth defects. Nat Genet 2007;39:1057-1059. (Pubitemid 47340640)
74. Loh ML, Reynolds MG, Vattikuti S, Gerbing RB, Alonzo TA, et al: PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group. Leukemia 2004;18:1831-1834. (Pubitemid 39530013)